Results 201 to 210 of about 1,616,867 (388)
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Lecanemab over a two-year duration: Key insights from a regional specialty medical center. [PDF]
Shields LBE +14 more
europepmc +1 more source
A. Furnary +7 more
semanticscholar +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Time of Day Drives Angiotensin II-Dependent Hypertension. [PDF]
Benson LN +3 more
europepmc +1 more source
L W, Gemmell, D R, Donaldson, C J, Smith
openaire +2 more sources
A study on green practice infusion of the SMES in the context of circular economy
Yi‐Hui Ho +3 more
openalex +2 more sources
Postoperative hepatic arterial infusion pump chemotherapy after resection of multinodular colorectal liver metastases [PDF]
Romane Brawermann +7 more
openalex +1 more source
Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller +17 more
wiley +1 more source

